Actively Recruiting

Age: 18Years +
All Genders
NCT06420999

Incidence and Impact of ICU-acquired Diaphragm Weakness

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-05-28

194

Participants Needed

1

Research Sites

182 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

ICU survivors are at an increased risk of hospital and ICU readmission. Among the complications of ICU stay, diaphragmatic dysfunction is common, with a prevalence of 60 to 80%, and is associated with increased mortality and prolonged hospital stays. Furthermore, several studies have reported that the observation of impaired respiratory muscle function upon ICU discharge is associated with a poor long-term prognosis. However, the incidence and prognostic impact of persistent diaphragmatic dysfunction at ICU discharge have never been evaluated. The measurement of dyspnea, a composite evaluation of respiratory muscle function, has not been assessed for predicting prognosis upon ICU discharge. The hypothesis of the project is that the presence of ICU-acquired diaphragmatic dysfunction at ICU discharge is associated with a poorer prognosis within 90 days.

CONDITIONS

Official Title

Incidence and Impact of ICU-acquired Diaphragm Weakness

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Received invasive or non-invasive respiratory support for at least 48 hours
  • Weaned from respiratory support within the last 24 hours
  • Patient or trusted person informed about the study and not opposed to participation
Not Eligible

You will not qualify if you...

  • Known pre-existing diaphragmatic dysfunction such as phrenic nerve injury or neuromuscular disease
  • Presence of a tracheostomy
  • Unable to communicate
  • Legally protected individuals under guardianship or deprived of liberty by court or administrative order

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Médecine intensive Réanimation

Paris, France, 75013

Actively Recruiting

Loading map...

Research Team

M

Martin Dres, MD,PHD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Incidence and Impact of ICU-acquired Diaphragm Weakness | DecenTrialz